Jessica St John to Humans
This is a "connection" page, showing publications Jessica St John has written about Humans.
Connection Strength
0.150
-
St John J, Strazzula L, Vedak P, Kroshinsky D. Estimating the health care costs associated with recurrent cellulitis managed in the outpatient setting. J Am Acad Dermatol. 2018 04; 78(4):749-753.
Score: 0.022
-
St John J, Vedak P, Garza-Mayers AC, Hoang MP, Nigwekar SU, Kroshinsky D. Location of skin lesions in Henoch-Sch?nlein purpura and its association with significant renal involvement. J Am Acad Dermatol. 2018 Jan; 78(1):115-120.
Score: 0.022
-
St John J, Ratushny V, Liu KJ, Bach DQ, Badri O, Gracey LE, Ho AW, Raff AB, Sugai DY, Schalock P, Kroshinsky D. Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children. Pediatr Dermatol. 2017 Sep; 34(5):540-546.
Score: 0.021
-
St John J, Summe H, Csikesz C, Wiss K, Hay B, Belazarian L. Multiple Caf? au Lait Spots in a Group of Fair-Skinned Children without Signs or Symptoms of Neurofibromatosis Type 1. Pediatr Dermatol. 2016 Sep; 33(5):526-9.
Score: 0.020
-
Tan AJ, Xia J, Glennon CM, Locascio JJ, Gabel CK, Nguyen ED, Chand S, Rrapi R, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D. Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study. J Am Acad Dermatol. 2024 Nov; 91(5):834-842.
Score: 0.009
-
Xia J, Tan AJ, Gabel CK, Nguyen ED, Chand S, Rrapi R, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D. Prevalence and risk factors for development of recurrent calciphylaxis. J Am Acad Dermatol. 2024 Jun; 90(6):1287-1289.
Score: 0.008
-
Gabel CK, Nguyen ED, Chakrala T, Blum AE, Fran?ois J, Chand S, Rrapi R, Baker O, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol. 2021 10; 85(4):1057-1064.
Score: 0.007
-
Gabel CK, Nguyen ED, Dobry AS, Baker O, Garza-Mayers AC, Ko LN, Shah R, St John J, Strazzula L, Nigwekar SU, Kroshinsky D. Assessment of outcomes of calciphylaxis lesions treated with intralesional sodium thiosulfate. J Am Acad Dermatol. 2021 09; 85(3):770-773.
Score: 0.006
-
Gabel C, Ko LN, Dobry AS, Garza-Mayers AC, Milne LW, Nguyen E, Parry BA, Raff A, Shah R, St John J, Strazzula L, Vedak P, Kroshinsky D. Patient preference for cellulitis treatment: At-home care is preferred to hospital-based treatment. J Am Acad Dermatol. 2021 09; 85(3):767-768.
Score: 0.006
-
Gabel C, Chakrala T, Shah R, Danesh MJ, Dobry AS, Garza-Mayers AC, Ko LN, Nguyen E, St John J, Walls AC, Nigwekar SU, Song PI, Kroshinsky D. Penile calciphylaxis: A retrospective case-control study. J Am Acad Dermatol. 2021 11; 85(5):1209-1217.
Score: 0.006
-
Baumrin E, Azzawi S, St John J, Hoang MP, Chen S, Bay CP, Kroshinsky D. Prognostic implications of normal or minimal urinary findings on long-term renal impairment in adults with Henoch-Sch?nlein purpura. J Am Acad Dermatol. 2020 Jun; 82(6):1393-1399.
Score: 0.006
-
Ko LN, Garza-Mayers AC, St John J, Strazzula L, Vedak P, Dobry AS, Kroshinsky D. Clinical Usefulness of Imaging and Blood Cultures in Cellulitis Evaluation. JAMA Intern Med. 2018 07 01; 178(7):994-996.
Score: 0.006
-
Ko LN, Garza-Mayers AC, St John J, Strazzula L, Vedak P, Shah R, Dobry AS, Rao SR, Milne LW, Parry BA, Kroshinsky D. Effect of Dermatology Consultation on Outcomes for Patients With Presumed Cellulitis: A Randomized Clinical Trial. JAMA Dermatol. 2018 05 01; 154(5):529-536.
Score: 0.006
-
Dobry AS, Ko LN, St John J, Sloan JM, Nigwekar S, Kroshinsky D. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study. JAMA Dermatol. 2018 02 01; 154(2):182-187.
Score: 0.005